Search

Cognilum Transcranial Photobiomodulation (JelikaLite Corp.) for Autism Spectrum Disorder

A wearable transcranial photobiomodulation (tPBM) device under investigation for the reduction of symptoms of moderate to severe autism spectrum disorder (ASD) in pediatric patients aged 2 to 6 years.

Complete this form to request the full report